{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:48:11Z","timestamp":1770274091203,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10067-020-05421-9","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T14:03:41Z","timestamp":1601474621000},"page":"693-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Toupin-April","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"5421_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28:437\u2013443","journal-title":"Pharmacotherapy"},{"key":"5421_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4065\/81.7.925","volume":"81","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW (2006) Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 81:925\u2013934","journal-title":"Mayo Clin Proc"},{"key":"5421_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/ard.2008.092619","volume":"68","author":"JA Singh","year":"2009","unstructured":"Singh JA, Hodges JS, Asch SM (2009) Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis 68:1265\u20131270","journal-title":"Ann Rheum Dis"},{"key":"5421_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, MacDonald PA, Lloyd E, Lademacher C (2009) Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 36:1273\u20131282","journal-title":"J Rheumatol"},{"key":"5421_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/RHU.0b013e3181945d2c","volume":"15","author":"R Halpern","year":"2009","unstructured":"Halpern R, Fuldeore MJ, Mody RR, Patel PA, Mikuls TR (2009) The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol 15:3\u20137","journal-title":"J Clin Rheumatol"},{"key":"5421_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N (2004) A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51:321\u2013325","journal-title":"Arthritis Rheum"},{"key":"5421_CR7","doi-asserted-by":"crossref","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM et al (2020) American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol 2020","DOI":"10.1002\/art.41247"},{"key":"5421_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/acr.20570","volume":"63","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R et al (2011) Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 63:1605\u20131612","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5421_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1471-2474-13-180","volume":"13","author":"LR Harrold","year":"2012","unstructured":"Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood RA (2012) Patients\u2019 knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskeletal Disorders 13:180","journal-title":"BMC Musculoskeletal Disorders"},{"key":"5421_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1742395310378761","volume":"6","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA (2010) Patients and providers view gout differently: a qualitative study. Chronic Illn 6:263\u2013271","journal-title":"Chronic Illn"},{"key":"5421_CR11","first-page":"CD001431","volume":"4","author":"D Stacey","year":"2017","unstructured":"Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 4:CD001431","journal-title":"Cochrane Database Syst Rev"},{"key":"5421_CR12","first-page":"828","volume":"10","author":"JB Perlin","year":"2004","unstructured":"Perlin JB, Kolodner RM, Roswell RH (2004) The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Am J Manag Care 10:828\u2013836","journal-title":"Am J Manag Care"},{"key":"5421_CR13","unstructured":"Jacobsen MJ, O\u2019connor AM, Stacey D. Decisional needs assessment in populations. \u00a9 1999 [updated 2013]. Link: https:\/\/decisionaid.ohri.ca\/docs\/implement\/Population_Needs.pdf. Available from www.ohri.ca\/decisionaid. Ottawa, Canada: Ottawa Health Research Institute; 2013 [09\/08\/2020]."},{"key":"5421_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0738-3991(98)00026-3","volume":"33","author":"AM O'Connor","year":"1998","unstructured":"O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, McPherson R, Bunn H, Graham I, Drake E (1998) A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 33:267\u2013279","journal-title":"Patient Educ Couns"},{"key":"5421_CR15","volume-title":"Enjoying research? A \u2018how-to\u2019 manual on needs assessment","author":"D Abbey-Livingston","year":"1982","unstructured":"Abbey-Livingston D, Abbey DS (1982) Enjoying research? A \u2018how-to\u2019 manual on needs assessment. Ontario Ministry of Tourism and Recreation, Toronto"},{"key":"5421_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pec.2006.04.010","volume":"63","author":"A Balde","year":"2006","unstructured":"Balde A, Legare F, Labrecque M (2006) Assessment of needs of men for decision support on male sterilization. Patient Educ Couns 63:301\u2013307","journal-title":"Patient Educ Couns"},{"key":"5421_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pec.2006.06.020","volume":"63","author":"M Doull","year":"2006","unstructured":"Doull M, O\u2019Connor A, Jacobsen MJ, Robinson V, Cook L, Nyamai-Kisia C, Tugwell P (2006) Investigating the decision-making needs of HIV-positive women in Africa using the Ottawa Decision-Support Framework: knowledge gaps and opportunities for intervention. Patient Educ Couns 63:279\u2013291","journal-title":"Patient Educ Couns"},{"key":"5421_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5737\/1181912x193117121","volume":"19","author":"LJ Jolicoeur","year":"2009","unstructured":"Jolicoeur LJ, O'Connor AM, Hopkins L, Graham ID (2009) Women\u2019s decision-making needs related to treatment for recurrent ovarian cancer: a pilot study. Can Oncol Nurs J 19:117\u2013121","journal-title":"Can Oncol Nurs J"},{"key":"5421_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pedn.2005.03.006","volume":"20","author":"K Kavanaugh","year":"2005","unstructured":"Kavanaugh K, Savage T, Kilpatrick S, Kimura R, Hershberger P (2005) Life support decisions for extremely premature infants: report of a pilot study. J Pediatr Nurs 20:347\u2013359","journal-title":"J Pediatr Nurs"},{"key":"5421_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1377\/hlthaff.26.3.716","volume":"26","author":"AM O\u2019Connor","year":"2007","unstructured":"O\u2019Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, Sodano AG, King JS (2007) Toward the \u2018tipping point\u2019: decision aids and informed patient choice. Health Aff (Millwood) 26:716\u2013725","journal-title":"Health Aff (Millwood)"},{"key":"5421_CR21","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/acr.20192","volume":"62","author":"JA Singh","year":"2010","unstructured":"Singh JA, Alpert MD, Kerr G (2010) A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken) 62:1306\u20131311","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5421_CR22","first-page":"1246","volume":"16","author":"PW Bull","year":"1989","unstructured":"Bull PW, Scott JT (1989) Intermittent control of hyperuricemia in the treatment of gout. J Rheumatol 16:1246\u20131248","journal-title":"J Rheumatol"},{"key":"5421_CR23","first-page":"1347","volume":"35","author":"SM Cummings","year":"2001","unstructured":"Cummings SM, Savitz LA, Konrad TR (2001) Reported response rates to mailed physician questionnaires. Health Serv Res 35:1347\u20131355","journal-title":"Health Serv Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05421-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:03:39Z","timestamp":1632960219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05421-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5421"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05421-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This was a QI initiative that only assessed opinions of healthcare providers and therefore an Institutional Review Board (IRB) approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/IRB approval and consent to participate"}},{"value":"No individual person\u2019s data were presented in any form in this study and therefore no consent to publish is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no financial conflicts related directly to this study. JAS has received consultant fees from Crealta\/Horizon, Medisys, Fidia, UBM LLC, Trio health, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Spherix, Practice Point communications, the National Institutes of Health, and the American College of Rheumatology. JAS owns stock options in Amarin pharmaceuticals and Viking therapeutics. JAS is on the speaker\u2019s bureau of Simply Speaking. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS served as a member of the American College of Rheumatology\u2019s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee. JR, KT, EC, and JB have no conflicts. There are no non-financial competing interests for any author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}